Big setback for Torrent Pharmaceuticals, company recalls 14 lots of Valsartan in US
The reason for the recall had been stated as an impurity, N-nitrosodimethylamine (NDMA), detected in the active pharmaceutical ingredients (API). NDMA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen by International Agency for Research on Cancer (IARC).
Ahmedabad-headquartered Torrent Pharmaceuticals, among the best performing pharma stocks, is voluntarily recalling 14 lots of high blood pressure medicine Valsartan in the US. Image source: Reuters